Rishika Sharma

A prospective randomized crossover trial studying the effects of maternal heartbeat and voice sounds on resting energy expenditure in preterm infants

Gurpreet Kaur, Sean M. Bailey, Elena Savvides, Heather B. Howell et autres

us (code pays fourni par la source)

Health and Economic Impact of Vein-to-Vein Time in CAR T-Cell Therapy in the Second-Line Treatment of Relapsed/Refractory Large B-Cell Lymphoma: A US Cost-Effectiveness Analysis

Olalekan O. Oluwole, Markqayne D Ray, Hongbo Ma, Rishika Sharma et autres

us (code pays fourni par la source)

Responsibility Index System (RISE): Enhancing Food Security and Safety with a Transparent, Blockchain-Based Accountability Framework

Rishika Sharma, Gourinath Banda

Effective management of semi-perishable food items is pivotal for minimizing waste, ensuring food safety, and advancing sustainability goals. This paper introduces the Responsibility Index System (RISE), a blockchain-powered framework aimed at fostering transparency and accountability within retail environments. While unprocessed food grains …

in (code pays fourni par la source)

RISE: Modular Blockchain-Integrated Enhancements for Reducing Food Waste and Boosting Retail Accountability

Rishika Sharma, Gourinath Banda

Effective management of semi-perishable food items is essential for minimising waste, maintaining food safety, and supporting sustainability efforts. This paper introduces the Responsibility Index for Sustainability and Efficiency (RISE), a set of modular components designed to seamlessly integrate with existing invoicing systems …

in (code pays fourni par la source)

A Cost-Effectiveness Analysis of Diffuse Large B-Cell Lymphoma Treatment Pathways in the United States

Anik R. Patel, Bradley Kievit, Ken Hasegawa, Markqayne Ray et autres

Background. Chimeric antigen receptor (CAR) T-cell therapies are approved as second-line (2L) or later therapy for diffuse large B-cell lymphoma (DLBCL). Recently, bispecific T-cell antibodies (BsAbs) have been approved as third-line (3L) treatments. The cost-effectiveness of different treatment sequences is unknown. This …

us (code pays fourni par la source)

Ensemble methods for computed tomography scan images to improve lung cancer detection and classification

Syeda Reeha Quasar, Rishika Sharma, Aayushi Mittal, Moolchand Sharma et autres

in, om, es (code pays fourni par la source)

Traffic Sign Detection and Recognition Using Ensemble Object Detection Models

Syeda Reeha Quasar, Rishika Sharma, Aayushi Mittal, Moolchand Sharma et autres

in, iq (code pays fourni par la source)

The cost-effectiveness of non-invasive stool-based colorectal cancer screening offerings from age 45 for a commercial and medicare population

Derek Ebner, John B. Kisiel, Lianne Barnieh, Rishika Sharma et autres

Aim: The United States Preventive Services Taskforce (USPSTF) recently recommended lowering the age for average-risk colorectal cancer (CRC) screening from 50 to 45 years.While initiating screening at age 45 versus 50 provides a greater opportunity for CRC early detection and prevention, the …

us (code pays fourni par la source)

Nanomedicine Applied to Inflammatory and Infectious Pulmonary Diseases

Arshdeep Kaur, Rishika Sharma, Isaac K. Sundar, P. Gopinath

in, us (code pays fourni par la source)

The cost-effectiveness of non-invasive stool-based colorectal cancer screening offerings from age 45 for a commercial and medicare population

Derek Ebner, John B. Kisiel, Lianne Barnieh, Rishika Sharma et autres

The United States Preventive Services Taskforce (USPSTF) recently recommended lowering the age for average-risk colorectal cancer (CRC) screening from 50 to 45 years. While initiating screening at age 45 versus 50 provides a greater opportunity for CRC early detection and prevention, the …

The cost-effectiveness of non-invasive stool-based colorectal cancer screening offerings from age 45 for a commercial and Medicare population

Derek Ebner, John B. Kisiel, Lianne Barnieh, Rishika Sharma et autres

The United States Preventive Services Taskforce (USPSTF) recently recommended lowering the age for average-risk colorectal cancer (CRC) screening from 50 to 45 years. While initiating screening at age 45 versus 50 provides greater opportunity for CRC early detection and prevention, the full …

Estimating recurrences prevented and costs avoided with atezolizumab in early non‐small cell lung cancer in the United States

Rishika Sharma, Sarika Ogale, Nathaniel J. Smith, Janet Shin Lee

BACKGROUND: Recurrence of early-stage non-small cell lung cancer (eNSCLC) is associated with significant mortality and costs. Atezolizumab (ATZ) was recently approved as adjuvant treatment following resection and platinum-based chemotherapy for adults with stage II-IIIA NSCLC with PD-L1 expression ≥1% after demonstrating significant …

us (code pays fourni par la source)